First Citizens Bank & Trust Co Cut Merck & Co (MRK) Stake; Tsakos Energy Navigation Limited (TNP) Had 7 Bullish Analysts

Merck & Co., Inc. (NYSE:MRK) Logo

Among 10 analysts covering Tsakos Energy Navigation Ltd (NYSE:TNP), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Tsakos Energy Navigation Ltd had 27 analyst reports since January 19, 2016 according to SRatingsIntel. Morgan Stanley maintained the stock with “Overweight” rating in Monday, February 12 report. Jefferies reinitiated Tsakos Energy Navigation Limited (NYSE:TNP) rating on Monday, December 18. Jefferies has “Buy” rating and $6 target. Jefferies maintained the shares of TNP in report on Monday, July 3 with “Buy” rating. On Thursday, April 7 the stock rating was maintained by JP Morgan with “Overweight”. The firm earned “Neutral” rating on Tuesday, July 26 by UBS. The company was maintained on Wednesday, June 1 by Morgan Stanley. The rating was maintained by Stifel Nicolaus on Friday, July 7 with “Buy”. Morgan Stanley maintained the shares of TNP in report on Monday, September 18 with “Overweight” rating. The company was maintained on Friday, September 15 by Stifel Nicolaus. The firm has “Overweight” rating by JP Morgan given on Tuesday, March 15. See Tsakos Energy Navigation Limited (NYSE:TNP) latest ratings:

23/03/2018 Broker: JP Morgan Old Rating: Overweight New Rating: Overweight Old Target: $5.5 New Target: $5 Maintain
13/03/2018 Broker: Maxim Group Old Rating: Buy New Rating: Buy Old Target: $6 New Target: $5 Maintain
12/02/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $5.5 New Target: $4 Maintain
24/01/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $6.0 Maintain
18/12/2017 Broker: Jefferies Old Rating: Buy New Rating: Buy New Target: $6 Reinitiate
27/10/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $7.0 Maintain

First Citizens Bank & Trust Co decreased Merck & Co Inc (MRK) stake by 63.03% reported in 2017Q4 SEC filing. First Citizens Bank & Trust Co sold 35,202 shares as Merck & Co Inc (MRK)’s stock declined 4.63%. The First Citizens Bank & Trust Co holds 20,652 shares with $1.16M value, down from 55,854 last quarter. Merck & Co Inc now has $157.93 billion valuation. The stock increased 2.59% or $1.48 during the last trading session, reaching $58.65. About 22.55 million shares traded or 76.64% up from the average. Merck & Co., Inc. (NYSE:MRK) has declined 14.94% since April 17, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Tsakos Energy Navigation Limited provides international seaborne crude oil and petroleum product transportation services worldwide. The company has market cap of $302.43 million. The firm offers marine transportation services to national, major, and other independent oil companies and refiners under long, medium, and short-term charters. It currently has negative earnings. As of April 5, 2017, it operated a fleet of 62 double-hull vessels, including 57 conventional tankers, 2 liquefied natural gas carriers, and 3 suezmax DP2 shuttle tankers.

The stock increased 0.29% or $0.01 during the last trading session, reaching $3.5. About 151,340 shares traded. Tsakos Energy Navigation Limited (NYSE:TNP) has declined 27.10% since April 17, 2017 and is downtrending. It has underperformed by 38.65% the S&P500.

First Citizens Bank & Trust Co increased Altria Group Inc (NYSE:MO) stake by 24,907 shares to 76,112 valued at $5.44M in 2017Q4. It also upped Pepsico Inc (NYSE:PEP) stake by 12,567 shares and now owns 37,754 shares. Morgan Stanley (NYSE:MS) was raised too.

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 19 have Buy rating, 0 Sell and 5 Hold. Therefore 79% are positive. Merck & Co. Inc. has $7400 highest and $50 lowest target. $65.28’s average target is 11.30% above currents $58.65 stock price. Merck & Co. Inc. had 84 analyst reports since August 13, 2015 according to SRatingsIntel. Jefferies maintained it with “Hold” rating and $54 target in Friday, April 15 report. The company was maintained on Wednesday, April 12 by Cowen & Co. The company was maintained on Friday, September 9 by Barclays Capital. The company was upgraded on Monday, March 12 by Leerink Swann. Piper Jaffray maintained the shares of MRK in report on Thursday, October 26 with “Buy” rating. The firm earned “Hold” rating on Thursday, August 27 by Berenberg. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Hold” rating by Jefferies on Thursday, July 14. On Monday, February 5 the stock rating was maintained by Credit Suisse with “Outperform”. The firm earned “Market Perform” rating on Monday, October 30 by Leerink Swann. JP Morgan maintained the stock with “Overweight” rating in Monday, September 21 report.

Investors sentiment decreased to 0.94 in Q4 2017. Its down 0.12, from 1.06 in 2017Q3. It turned negative, as 94 investors sold MRK shares while 631 reduced holdings. 123 funds opened positions while 558 raised stakes. 1.93 billion shares or 1.34% less from 1.96 billion shares in 2017Q3 were reported. Tarbox Family Office holds 3,580 shares or 0.08% of its portfolio. Folger Nolan Fleming Douglas Cap Inc holds 0.56% or 71,059 shares. King Wealth Grp Inc Ltd Llc holds 7,015 shares or 0.14% of its portfolio. Lourd Ltd Liability Company has invested 0.05% in Merck & Co., Inc. (NYSE:MRK). & Mngmt invested in 0.62% or 35,827 shares. Wealthtrust Fairport Ltd Liability invested 0.15% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Sectoral Asset Mngmt has 0.76% invested in Merck & Co., Inc. (NYSE:MRK) for 108,501 shares. Gm Advisory Gru holds 0.08% or 5,155 shares in its portfolio. Alyeska Group Limited Partnership holds 1.75 million shares or 0.85% of its portfolio. Lincluden Mgmt holds 0.31% or 80,615 shares. Cleararc Cap accumulated 62,180 shares. Winslow Evans And Crocker has invested 0.43% in Merck & Co., Inc. (NYSE:MRK). Arcadia Investment Mngmt Mi accumulated 1,100 shares. Kistler owns 46,584 shares or 1.03% of their US portfolio. Earnest Prtn Limited Liability Corporation holds 1,317 shares or 0% of its portfolio.

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on May, 1 before the open. They expect $0.99 EPS, up 12.50% or $0.11 from last year’s $0.88 per share. MRK’s profit will be $2.67 billion for 14.81 P/E if the $0.99 EPS becomes a reality. After $0.98 actual EPS reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts 1.02% EPS growth.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart